# Safety and Efficacy Study of Intravenous Immunoglobulin to Treat Japanese Encephalitis

> **NCT01856205** · PHASE2 · COMPLETED · sponsor: **University of Liverpool** · enrollment: 22 (actual)

## Conditions studied

- Japanese Encephalitis

## Interventions

- **DRUG:** Intravenous immunoglobulin [ImmunoRel™ (batch 20081217)]

## Key facts

- **NCT ID:** NCT01856205
- **Lead sponsor:** University of Liverpool
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2009-08
- **Final completion:** 2009-08
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2013-05-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01856205

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01856205, "Safety and Efficacy Study of Intravenous Immunoglobulin to Treat Japanese Encephalitis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01856205. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*